Control Bionics Ltd. · ASX:CBL
Control Bionics — Investor Presentation (October 2021)
16 slides from Control Bionics's investor presentation, Oct 22, 2021
Slide 1: Control Bionics - ShareCafe October 2021
control bionics For personal use only SHARECAFE October 22 2021 Control Bionics Limited ABN 45 115 465 462
Slide 2: Disclaimer
Disclaimer For personal use only This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter covered in it. The information in this presentation, whether written or verbal, has been prepared without taking into account the co
Slide 3: Make a life-changing connection
make a life–changing For personal use only connection Annual General Meeting | October 13, 2021 3
Slide 4: Mission
mission For personal use only To be the global leader in innovative augmentative communications and control devices Annual General Meeting | October 13, 2021 4
Slide 5: Life-changing connection
Me A & vy x Ss LIFE-CHANGING . J CONNECTION “i a ~
Slide 6: Our Products
Our Products • World class patented NeuroNode technology For personal use only • Two primary assistive communication technology solutions for disability sector globally Annual General Meeting | October 13, 2021 6
Slide 7: Completion of IPO Dec 2020
Completion of IPO Dec 2020 For personal use only • Successful IPO in December 2020 raising $15m • World class assistive technology and the opportunity to address a $1.2 Billion market in USA, Australia and Japan alone • Patented technology • Significant global potential to grow the business and trul
Slide 8: Exciting, Successful & Challenging FY21
Exciting, SuCCESSFUL & Challenging FY21 • Revenue of $3.97m For personal use only • Investment year with 28% YOY growth in revenue despite COVID-19 business impact • Solid growth in key regions of USA and Australia • Strong balance sheet with $12.3m in cash as at June 30th Annual General Meeting | O
Slide 9: The year ahead
For personal use only the year ahead Annual General Meeting | October 13, 2021 9
Slide 10: Significant Addressable Market
Significant Addressable Market ($1.2 Billion – Australia, USA, Japan) For personal use only Annual General Meeting | October 13, 2021 10
Slide 11: Momentum with Senior Global Management Team
Momentum with Senior Global Management Team For personal use only Rob Wong Neale Java Todd Tyler Annette Curry Peter Ford James Schorey CEO CFO Vice President Australia Region Director of Innovation CTO North America Sales Director – new markets Chris Feighner Stacey Berard Jamie Lemsing Meagan Koen
Slide 12: Key Priorities 2021/22
Key Priorities 2021/22 • Revenue Growth For personal use only • Revenue growth focus in Australia and North America through partners and sales team channels post COVID-19 • Operating Expenditure • Optimise productivity and strategic investments • Product leadership • NEW branding and marketing inves
Slide 13: Product Range 2021/22
Product Range 2021/22 For personal use only ` Annual General Meeting | October 13, 2021 13
Slide 14: New Product
New Product For personal use only Annual General Meeting | October 13, 2021 14
Slide 15: Innovation
innovation • More control & monitoring applications • R&D partnership with Deakin University: For personal use only to disability markets and beyond through wheelchair control miniaturisation of tech Annual General Meeting | October 13, 2021 15
Slide 16: Contact
contact For personal use only Rob Wong Brett Crowley CEO Company Secretary robwong@controlbionics.com brettcrowley@controlbionics.com +61 419238768 +61 3 9897 3576 Annual General Meeting | October 13, 2021 16
Control Bionics — Investor Presentation (October 2021) on 6ix